Walgreens agrees to pay nearly $230 million for San Francisco opioid settlement
San Francisco said on Wednesday it reached a $230 million settlement with Walgreens Boots Alliance Inc over its role in the city’s opioid epidemic.
FDA considering approval of first over-the-counter birth control pill
The Food and Drug Administration is nearing its decision on whether to allow HRA Pharma to sell its Opill birth control pill in the U.S. without requiring a prescription.
Family Dollar recalls Advil stored outside of temperature requirements
Family Dollar issued another recall for several over-the-counter drug products after discovering they were not stored under proper conditions, according to a notice from the FDA.
Novo Nordisk cuts supply of certain Wegovy doses as it faces strong demand
Novo Nordisk will only be able to supply limited quantities of certain Wegovy dose strengths to U.S. retail pharmacies given the surge in demand for the product.
This is the way? 'JEDI Center' uses magic mushrooms for guided 'journeys'
Entrepreneurs in Vancouver are offering psilocybin "journeys" for clients seeking what they describe as "the highest level of self-discovery and personal development."
Adderall, Ozempic and other drug shortages have no clear resolution and could exist for years, experts say
Experts say national drug shortages, caused by manufacturing problems, demand spikes, and tightened ingredient supply lines, have no clear resolution and could persist for years.
Diabetes drug tested for weight loss could be game changer
Eli Lilly's tirzepatide, which is approved to treat Type 2 diabetes and sold under the brand name Mounjaro, could become the most effective weight loss treatment.
What Is Ozempic and why is it such a big deal right now?
Demand for medications including Ozempic, for weight loss use, led to shortages that sometimes deprived people with diabetes of their prescription refills.
Americans spent more on legal cannabis in 2022 than chocolate, beer: report
Americans are spending more money on legal cannabis purchases than they are spending on chocolate, craft beer, opioid medications or topical pain relief.
Narcan maker aims to make overdose reversal drug more affordable, company says
Emergent BioSolutions is aiming to make Narcan more affordable after the Food and Drug Administration approved sales of the live-saving without a prescription.
Moderna's flu shot faces setback, shares fall
Moderna shares are down Tuesday on news that the biotech's potential flu vaccine will need further review to determine its efficacy against influenza.
Wrestling legend Ric Flair launches new cannabis company: Edibles changed my life
Pro wrestling icon Ric Flair and co-founder of ‘Drip Cannabis’ Chad Bronstein share why they launched a cannabis company on 'Kennedy.'
Deadly fungus and companies with potential treatment
The U.S. Food and Drug Administration approved Cidara Therapeutics and Melinta Therapeutics' antifungal drug for patients with little to no other options.
DOJ sues Rite Aid for alleged involvement in opioid crisis
The Justice Department filed a lawsuit against Rite Aid for allegedly filling out "hundreds of thousands" of unlawful prescriptions, contributing to the opioid crisis.
US probe of dog breeder scrutinizes why USDA left thousands of beagles to suffer
USDA took no action against drug maker Envigo who had to forfeit 4,000 beagles after mistreating them. Envigo settled civil charges but Grand Jury explores legal options.
New drugs are coming to market at sky-high prices
To avoid government penalties for raising drug prices, pharmaceutical companies are releasing drugs at higher prices with hefty rebates to maintain profitability.
Wegovy, Ozempic: The barriers to accessing these weight loss drugs
Doctors tell FOX Business that there are a handful of barriers keeping people from being able to take Wegovy and Ozempic including insurance coverage, high cost and availability issues.
FDA to decide on full approval of Alzheimer's treatment Leqembi in early July
The FDA will decide on July 6 whether to grant full approval to the new Alzheimer's treatment Leqembi, Japanese drugmaker Eisai and its U.S. partner Biogen said.
Family sues Airbnb after toddler dies of fentanyl overdose in rental
The Lavenir family filed a wrongful death lawsuit against Airbnb, a rental owner, and the prior renter after their 19-month-old daughter died due to fentanyl exposure.
Washington offering drug offenders priority status for 'social equity' licenses to sell weed
The Washington State Liquor and Cannabis Board is offering available retail licenses to sell marijuana, prioritizing former offenders in the name of "social equity."